// App-Quantinova.ai

e20028 : Normal-lung uptake of fluorodeoxyglucose, patient-reported symptoms, and clinician-rated radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation. - Publication Only: Lung CancerNon-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Researchers

Presenter

  • Jinbo Yue

Principal Investigators

  • Ting Xu

  • Tingsu Pan

  • Melenda Jeter

  • Quynh Nguyen

  • Lawrence B. Levy

  • Qiuling Shi

  • Ritsuko Komaki

  • Daniel Richard Gomez

  • Xin Shelley Wang

  • Zhongxing X. Liao

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Pulmonary alveolar proteinosis

  • Solid malignancies

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT00915005

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved